Live Breaking News & Updates on Lal pathlabs limited

Stay informed with the latest breaking news from Lal pathlabs limited on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lal pathlabs limited and stay connected to the pulse of your community

Share Market Highlights 02 November 2023: Sensex gains 490 pts, Nifty closes above 19,100 as Federal Reserve's dovish stance drives markets higher

Share Market Highlights 02 November 2023: Sensex gains 490 pts, Nifty closes above 19,100 as Federal Reserve's dovish stance drives markets higher
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Miraj , Maharashtra , India , Chhattisgarh , Zurich , Züsz , Switzerland , Uttar-pradesh , Germany , Indas , West-bengal , Bengaluru

India Diagnostic Labs Market Report 2023: Growing Awareness Related to Preventive Medicine Fuels the Sector

/PRNewswire/ -- The "India Diagnostic Labs Market By Provider Type (Stand-Alone Diagnostic Labs, Hospital Diagnostic Labs, Diagnostic Chains), By Test Type...

Brazil , India , Australia , United-kingdom , Dublin , Ireland , Lal-pathlabs , Laura-wood , Thyrocare-technologies , Quest-diagnostics-india-pvt-ltd , E-st-office-hours-call , Health-services-pvt

Dr Lal PathLabs rewards employees with 16,000 shares as stock options

The shares were allotted under the ESOP 2010 Plan of the company.

Lal-pathlabs , Vinay-gujral , Lal-pathlabs-limited , Dr-lal-pathlabs , Employees , Esops , Esos , Shares ,

Dr Lal PathLabs Ltd appoints Vinay Gujral as Compliance Officer

Dr. Lal PathLabs Limited announced via an exchange filing that the Board of Directors, vide their resolution dated March 21, 2023, have:

a) Noted the resignation of Rajat Kalra as Company Secretary & Compliance Officer of the Company. His last working day will be March 31, 2023 (Closing of business hours);

b) Approved the appointment of Vinay Gujral (ACS 25995) as Compliance Officer

Lal-pathlabs , Rajat-kalra-as-company , Lal-pathlabs-limited , Rajat-kalra , Company-secretary , Compliance-officer , Vinay-gujral , Dr-lal-pathlabs- , Appoints- , Vinay-gujral- , Resignation-

Dr Lal PathLabs selects Kyndryl for seamless cloud services management

New Delhi [India], March 15 (ANI/NewsVoir): Dr Lal PathLabs Limited, one of India's leading pathology diagnostic providers with more than 250 laboratories and 4500 sample collection points, has appointed Kyndryl (NYSE: KD), the world's largest IT infrastructure services provider, to manage its IT infrastructure stack, including both the on-premises IT environment and cloud infrastructure across multiple hyperscaler cloud service providers. Post onboarding, Kyndryl has been instrumental in managing the multiple cloud platforms that play a key role in Dr Lal PathLabs' digital transformation initiatives to drive business growth. Kyndryl provides a single pane view of server utilization, service requests, ticketing lifecycle, incident analysis, and also recommends proactive remediation. Offering a unified view of their infrastructure utilization on-premises and across multiple public cloud environments has improved service availability and helped Dr Lal Pathlabs reduce IT incidents by a substantial margin. Kyndryl has also integrated compliance checks such as inventory management, patching, and security health, which have helped achieve continuous compliance within Dr Lal PathLabs' cloud environment and security posture. Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces related to reliability, performance and availability. The service availability uptime enabled Dr Lal PathLabs to focus on enhancing customer satisfaction and reducing call center workload spikes by a double-digit percentage. During the COVID-19 pandemic, Dr Lal PathLabs relied on Kyndryl's technology expertise to make critical changes in its cloud infrastructure on an almost daily basis to fulfill modifications as required by policymakers to aid efforts in controlling the spread. Kyndryl-managed IT infrastructure hosts Dr Lal PathLabs' entire suite of enterprise applications, digital properties and other utility tools. This enables Dr Lal PathLabs to track its entire lab testing process, predict and manage delays, and deliver new age strategic initiatives such as AI-based algorithms and data science to boost delivery efficiency. Kyndryl also has the ability to tap into a broad set of technologies and skills, and strategic alliances with hyperscalers in support of Dr Lal PathLabs' transformation goals. "Dr. Lal PathLabs has been at the forefront of diagnostic services and leveraging new technology to drive business growth. The expansion of our customer base and range of services we provide means we need to invest in our digital transformation to make us future ready, resilient, and adaptable to change. Kyndryl has proven to be an able partner in this journey with us," said Bharath Uppiliappan, CEO, Dr. Lal PathLabs. "Understanding the criticality of response and resolution time in the healthcare industry, and efficiently managing it through its multi-cloud management solution has been Kyndryl's significant contribution. From seamlessly managing our IT infrastructure to countering outages and handling change management -- especially during the COVID-19 pandemic -- Kyndryl's deep industry expertise and delivery capabilities are helping us to effectively provide best-of-class customer experience and fast-track our digital transformation journey," said Munender Soperna, Chief Information Officer, Dr Lal PathLabs. "Cloud and artificial intelligence have led to some truly innovative approaches to traditional business models. This was evident during the pandemic when several industries, especially healthcare service providers, were forced to adapt to the new normal almost overnight. Kyndryl's multi-cloud management expertise helps Dr Lal PathLabs handle change management when adapting to sudden market and regulatory requirements, yet allows them the flexibility to design and provide a premium service experience tailored for every customer," said Lingraju Sawkar, President, Kyndryl India. Dr Lal PathLabs is India's foremost network of diagnostics labs with 277 clinical labs, nearly 5,000 patient service centres and over 10,599 pickup-up points offering a range of diagnostic services. Dr Lal PathLabs Ltd. enjoys the trust of over 27 million patients every year and is the preferred diagnostic chain for walk-in patients, pre-employment and employee diagnostics for corporates and caters to hospitals, through an agile B2B model. The robust network, built on reliable transport of biological samples, their processing and timely and accurate reporting, is supported by a National Reference Laboratory in New Delhi, a Reference Laboratory in Kolkata and 275 other clinical laboratories backed by a nearly 5,100 strong manpower. Dr Lal PathLabs offers an exhaustive range of Pathology, and a super-specialized menu of tests like high-end Molecular Diagnostics, Cytogenomics, Transplant Immunology, Transmission Electron Microscopy and more. Recently, Dr. Lal PathLabs Limited tied up with a multinational company to offer comprehensive precision oncology and high-end onco-pathology service and would continue to partner with global providers of the largest and most advanced diagnostic solutions. Kyndryl (NYSE: KD) is the world's largest IT infrastructure services provider, serving thousands of enterprise customers in more than 60 countries. The Company designs, builds, manages, and modernizes the complex, mission-critical information systems that the world depends on every day. For more information, visit www.kyndryl.com. This story has been provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Kolkata , West-bengal , India , New-delhi , Delhi , Lingraju-sawkar , Bharath-uppiliappan , Lal-pathlabs , Lal-pathlab , Munender-soperna , Reference-laboratory , Dr-lal-pathlabs

Dr. Lal PathLabs Selects Kyndryl for Seamless Cloud Services Management

Dr. Lal PathLabs Ltd has appointed Kyndryl, to manage its IT infrastructure stack, including both the on-premises IT environment and cloud infrastructure across multiple hyperscaler cloud service providers.

India , Lingraju-sawkar , Bharath-uppiliappan , Lal-pathlabs , Lal-pathlab , Munender-soperna , Seamless-cloud-services-management , Lal-path-labs-ltd , Lal-pathlabs-selects-kyndryl , Seamless-cloud-services , Lal-pathlabs-limited , Chief-information-officer

India Healthcare Market Analysis Report 2021: Impact of COVID-19, Market Segments, Government Initia

DUBLIN--(BUSINESS WIRE)--The "Healthcare Market in India 2021" report has been added to ResearchAndMarkets.com's offering.India's healthcare market was valued at INR 17.62 Trn in 2020. It is expected to expand at a compound annual growth rate (CAGR) of ~29.79% during the 2021-2026 period to reach INR 81.30 Trn by 20...

India , Kerala , Laura-wood , Columbia-asia-hospitals-private , Lal-pathlabs , Aster-dm-healthcare , India-medical-research , India-diagnostic-services-segment , Narayana-hrudayalaya , India-pharmaceuticals-segment , Cipla , India-outpatient-care-services-segment

LIC buys stake in this healthcare firm, stock surges over 2%

Shares of the healthcare provider rose 2.59% to Rs 3,768 against the previous close for Rs 3,673 on BSE.

Delhi , India , Lal-pathlabs , Life-insurance-corporation , Lal-pathlabs-limited , Lic-stake-in-dr-lal-pathlabs , R-lal-pathlabs-share-rises , R-lal-pathlabs , R-lal-pathlabs-stock , Ic-buys-stake-in-dr-lal-pathlabs ,

India Digest: Chalo acquires Shuttl; Dr Lal PathLabs buys Suburban Diagnostics

Public transport tech company Chalo has acquired Amazon-backed Shuttl, an app-based office commute bus aggregator, for an undisclosed sum.

Kolkata , West-bengal , India , Bangkok , Krung-thep-mahanakhon , Thailand , Delhi , Mumbai , Maharashtra , Hyderabad , Andhra-pradesh , Pune

Dr Lal PathLabs - Q1 FY22 first cut - Beat across the board - YES Securities

Dr Lal PathLabs - Q1 FY22 first cut - Beat across the board - YES Securities
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Lal-pathlabs , Time-zone , Lal-pathlabs-limited , லால்-பாதைகள் , நேரம்-ஸோந் , லால்-பாதைகள்-வரையறுக்கப்பட்டவை ,